Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers of Cervical Spondylotic Myelopathy
Sponsor: University of California, San Francisco
Summary
We believe that patients with cervical spondylotic myelopathy (CSM) have measurable changes in certain molecules in their blood compared with people without CSM. We expect that these changes may be related to how severe a patient's condition is based on imaging and clinical exams. We will also study how these molecules change before and after surgery to see whether they are related to how well patients recover. By combining these blood markers with clinical and imaging information, we hope to develop a tool that may help predict patient outcomes.
Official title: Investigating -Omic Features and Prognostic Indicators of Cervical Spondylotic Myelopathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2026-09
Completion Date
2030-09
Last Updated
2026-08-19
Healthy Volunteers
Yes
Conditions
Locations (1)
UCSF Medical Center
San Francisco, California, United States